PubMed

A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone.

Schleinitz MD, Heidenreich PA.

Ann Intern Med. 2005 Feb 15;142(4):251-9.PMID: 15710958 [PubMed - indexed for MEDLINE]Related articlesFree article

Clopidogrel: a pharmacoeconomic review of its use in patients with non-ST elevation acute coronary syndromes.

Lyseng-Williamson KA, Plosker GL.

Pharmacoeconomics. 2006;24(7):709-26. Review.PMID: 16802846 [PubMed - indexed for MEDLINE]Related articles

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.PMID: 15461876 [PubMed - indexed for MEDLINE]Related articlesFree article

Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis.

Schleinitz MD, Weiss JP, Owens DK.

Am J Med. 2004 Jun 15;116(12):797-806.PMID: 15178495 [PubMed - indexed for MEDLINE]Related articles

Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation.

Main C, Palmer S, Griffin S, Jones L, Orton V, Sculpher M, Henderson R, Sudlow C, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(40):iii-iv, xv-xvi, 1-141. Review.PMID: 15461878 [PubMed - indexed for MEDLINE]Related articlesFree article

The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.

Lindgren P, Stenestrand U, Malmberg K, Jönsson B.

Clin Ther. 2005 Jan;27(1):100-10.PMID: 15763611 [PubMed - indexed for MEDLINE]Related articles

Long-term clopidogrel therapy in patients receiving percutaneous coronary intervention.

Heeg BM, Peters RJ, Botteman M, van Hout BA.

Pharmacoeconomics. 2007;25(9):769-82.PMID: 17803335 [PubMed - indexed for MEDLINE]Related articles

Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation.

Weintraub WS, Mahoney EM, Lamy A, Culler S, Yuan Y, Caro J, Gabriel S, Yusuf S; CURE Study Investigators.

J Am Coll Cardiol. 2005 Mar 15;45(6):838-45.PMID: 15766816 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trial.

Kolm P, Yuan Y, Veledar E, Mehta SR, O'Brien JA, Weintraub WS.

Can J Cardiol. 2007 Nov;23(13):1037-42.PMID: 17985004 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial.

Chen J, Bhatt DL, Dunn ES, Shi C, Caro JJ, Mahoney EM, Gabriel S, Jackson JD, Topol EJ, Cohen DJ.

Value Health. 2009 Sep;12(6):872-9. Epub 2009 Mar 11.PMID: 19490556 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.

Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, Goldman L.

N Engl J Med. 2002 Jun 6;346(23):1800-6.PMID: 12050341 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Is it cost-effective to treat high-risk cardiac patients with clopidogrel plus aspirin as opposed to aspirin alone?

[No authors listed]

Ann Intern Med. 2005 Feb 15;142(4):I53. No abstract available. PMID: 15710954 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack.

Sarasin FP, Gaspoz JM, Bounameaux H.

Arch Intern Med. 2000 Oct 9;160(18):2773-8.PMID: 11025787 [PubMed - indexed for MEDLINE]Related articlesFree article

Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK.

Karnon J, Brennan A, Pandor A, Fowkes G, Lee A, Gray D, Coshall C, Nicholls C, Akehurst R.

Curr Med Res Opin. 2005 Jan;21(1):101-12.PMID: 15881481 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation.

Catherwood E, Fitzpatrick WD, Greenberg ML, Holzberger PT, Malenka DJ, Gerling BR, Birkmeyer JD.

Ann Intern Med. 1999 Apr 20;130(8):625-36.PMID: 10215558 [PubMed - indexed for MEDLINE]Related articlesFree article

A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK.

Karnon J, Bakhai A, Brennan A, Pandor A, Flather M, Warren E, Gray D, Akehurst R.

Int J Cardiol. 2006 May 24;109(3):307-16. Epub 2005 Jul 18.PMID: 16026869 [PubMed - indexed for MEDLINE]Related articles

Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.

Beinart SC, Kolm P, Veledar E, Zhang Z, Mahoney EM, Bouin O, Gabriel S, Jackson J, Chen R, Caro J, Steinhubl S, Topol E, Weintraub WS.

J Am Coll Cardiol. 2005 Sep 6;46(5):761-9.PMID: 16139122 [PubMed - indexed for MEDLINE]Related articles

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis.

Pignone M, Earnshaw S, Tice JA, Pletcher MJ.

Ann Intern Med. 2006 Mar 7;144(5):326-36.PMID: 16520473 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation.

Mahoney EM, Mehta S, Yuan Y, Jackson J, Chen R, Gabriel S, Lamy A, Culler S, Caro J, Yusuf S, Weintraub WS; CURE Study Investigators.

Am Heart J. 2006 Jan;151(1):219-27.PMID: 16368322 [PubMed - indexed for MEDLINE]Related articles

The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis.

Rogowski W, Burch J, Palmer S, Craigs C, Golder S, Woolacott N.

Health Technol Assess. 2009 Jun;13(31):iii-iv, ix-xi, 1-77. Review.PMID: 19573471 [PubMed - indexed for MEDLINE]Related articlesFree article